Urticaria and hyposideremia: a case report

Annunziata Bartolotta, Fabrizio Guarneri, Serafinella P Cannavò

Abstract


The authors report the case of an 86-year-old man with a six-month history of chronic idiopathic urticaria, refractory to standard treatments. The patient did not report concomitant diseases and all clinical tests performed were normal. Laboratory tests showed only mild anemia and low serum iron (31 mcg/dl, normal value 59-158). After oral iron supplementation (105 mg/day of elemental iron, taken as ferrous sulphate) for two months, normal serum iron levels and complete remission of urticaria were observed. No further episodes of urticaria were reported at follow-up visits, six and twelve months later.


The possible link between hyposideremia and urticaria is also discussed. In vitro experimental data suggest that transferrin inhibits histamine release from mast cells, and a direct correlation exists between the level of transferrin saturation and the degree of inhibition of histamine release. Reduced transferrin saturation due to hyposideremia could lower the threshold of stimulation required for mast cell degranulation, thus increasing the risk of urticaria in response to endogenous and/or exogenous pathogenic stimuli, even minimal. Further studies are necessary to better understand frequency and pathogenic mechanism(s) of “sideropenic urticaria” (chronic urticaria associated with hyposideremia and favourably responding to iron supplementation). From a clinical point of view, evaluation of serum iron levels in selected patients appears advisable, in the light of the relatively low cost and possible significant benefits

Keywords


chronic urticaria; hyposideremia; etiopathogenesis; iron supplementation; therapy

Full Text:

PDF

References


Guarneri, F., Guarneri, C., Cannavò, S.P. (2014). Oral iron therapy and chronic idiopathic urticaria: sideropenic urticaria? Dermatol Ther, 27(4), 223-226. doi: 10.1111/dth.12122.

Franzini, C., Berlusconi, A., Favarelli, C., Brambilla, S. (2000). Low frequency of elevated serum transferrin saturation in elderly subjects. Clin Chim Acta, 298(1-2), 181-186.

Lapi, F., Cassano, N., Pegoraro, V., Cataldo, N., Heiman, F., Cricelli, I., Levi, M., Colombo, D., Zagni, E., Cricelli, C., Vena, G.A. (2016). Epidemiology of chronic spontaneous urticaria: results from a nationwide, population-based study in Italy. Br J Dermatol, 174(5), 996-1004. doi: 10.1111/bjd.14470.

Giménez Camarasa, J.M., Alomar, A. (1975). Chronic urticaria and serum iron. Med Cutan Ibero Lat Am, 3(3), 247-252.

Sharma, A.D. (2010). Benefit of iron therapy in the management of chronic urticaria due to nickel sensitivity. Indian J Dermatol, 55(4), 407-408. doi: 10.4103/0019-5154.74576.

Wu, C.H., Eren, E., Ardern-Jones, M.R., Venter, C. (2015). Association between micronutrient levels and chronic spontaneous urticaria. Biomed Res Int, 2015: 926167. doi: 10.1155/2015/926167.

Powell, R.J., Leech, S.C., Till, S., Huber, P.A., Nasser, S.M., Clark, A.T., British Society for Allergy and Clinical Immunology. (2015). BSACI guideline for the management of chronic urticaria and angioedema. Clin Exp Allergy, 45(3), 547-565. doi: 10.1111/cea.12494.

Gross-Weege, W., Theobald, K., König, W. (1986). Inhibition of histamine release from rat peritoneal mast cells by a factor from human serum--identification as transferrin. Agents Actions, 19(1-2), 10-17.

Theobald, K., Gross-Weege, W., Keymling, J., König, W. (1987). Purification of serum proteins with inhibitory activity on the histamine release in vitro and/or in vivo. Int Arch Allergy Appl Immunol, 82(3-4), 295-297.

Theobald, K., Gross-Weege, W., Keymling, J., König, W. (1987). Inhibition of histamine release in vitro by a blocking factor from human serum: comparison with the iron binding proteins transferrin and lactoferrin. Agents Actions, 20(1-2), 10-16.




DOI: https://doi.org/10.6092/1828-6550/APMB.105.1.2017.A4

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Annunziata Bartolotta, Fabrizio Guarneri, Serafinella P Cannavò

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.